Quarterly report pursuant to Section 13 or 15(d)

CONSOLIDATED STATEMENTS OF CASH FLOWS

v3.21.2
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Millions
6 Months Ended
Jun. 30, 2021
Jun. 30, 2020
Cash flows from operating activities:    
Net earnings (loss) $ 162 $ 1,248
Adjustments to reconcile net earnings to net cash provided by operating activities    
Depreciation and amortization 717 618
Stock compensation expense 87 164
Impairment 0 72
Loss on debt extinguishment 46 44
Deferred income taxes (76) 17
Gain on divestiture 62 (104)
Other adjustments, net 14 2
Changes in assets and liabilities    
Premium and trade receivables (1,514) (1,159)
Other assets (458) 202
Medical claims liabilities 325 146
Unearned revenue (83) (127)
Accounts payable and accrued expenses 1,285 1,309
Other long-term liabilities 1,161 1,028
Other operating activities, net 0 14
Net cash provided by operating activities 1,728 3,474
Cash flows from investing activities:    
Capital expenditures (437) (412)
Purchases of investments (3,590) (1,849)
Sales and maturities of investments 2,809 1,768
Acquisitions, net of cash acquired (140) (3,000)
Divestiture proceeds, net of divested cash (62) 466
Other investing activities, net 0 (5)
Net cash used in investing activities (1,420) (3,032)
Cash flows from financing activities:    
Proceeds from long-term debt 2,398 2,630
Payments of long-term debt (2,353) (1,598)
Common stock repurchases (33) (561)
Payments for debt extinguishment (54) (21)
Debt issuance costs (28) (93)
Other financing activities, net 24 22
Net cash provided by (used in) financing activities (46) 379
Effect of exchange rate changes on cash, cash equivalents, and restricted cash (24) 3
Net increase in cash, cash equivalents and restricted cash and cash equivalents 238 824
Cash, cash equivalents, and restricted cash and cash equivalents, beginning of period 10,957 12,131
Cash, cash equivalents, and restricted cash and cash equivalents, end of period 11,195 12,955
Supplemental disclosures of cash flow information:    
Interest paid 355 360
Income taxes paid 406 75
Equity issued in connection with acquisitions 0 11,526
The following table provides a reconciliation of cash, cash equivalents, and restricted cash and cash equivalents reported within the Consolidated Balance Sheets to the totals above:    
Cash and cash equivalents 11,018 12,798
Restricted cash and cash equivalents, included in restricted deposits 177 157
Total cash, cash equivalents, and restricted cash and cash equivalents $ 11,195 $ 12,955